» Authors » Jon A Cokley

Jon A Cokley

Explore the profile of Jon A Cokley including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 22
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yarimi J, Sandweiss A, Salazar K, Massrey C, Ankar A, Muscal E, et al.
J Neuroimmunol . 2024 Aug; 395:578430. PMID: 39128431
New-onset refractory status epilepticus (NORSE) is a devastating clinical condition that often leads to severe disability. Intrathecal dexamethasone (IT-DEX) has been reported to improve refractory status epilepticus. We present an...
2.
Cokley J, Lazar S
Semin Pediatr Neurol . 2024 Apr; 49:101119. PMID: 38677803
Clinical pharmacists are a part of the integrated health care team and provide valuable input on medication management for patients with acute and chronic disease states. Using epilepsy as a...
3.
Muller P, Takacs D, Hedrich U, Coorg R, Masters L, Glinton K, et al.
Ann Clin Transl Neurol . 2023 Feb; 10(4):656-663. PMID: 36793218
Precision medicine for Mendelian epilepsy is rapidly developing. We describe an early infant with severely pharmacoresistant multifocal epilepsy. Exome sequencing revealed the de novo variant p.(Leu296Phe) in the gene KCNA1,...
4.
Cokley J, Gidal B, Keller J, Vossler D
Epilepsy Curr . 2022 Dec; 22(3):201-204. PMID: 36451851
This American Epilepsy Society (AES) official statement provides information and preliminary guidance to Society members related to the U.S. Food & Drug Administration (FDA) December 22, 2021 Emergency Use Authorization...
5.
Thomas A, Riviello Jr J, Davila-Williams D, Thomas S, Erklauer J, Bauer D, et al.
Curr Treat Options Neurol . 2022 Jun; 24(7):285-304. PMID: 35702419
Purpose Of Review: This review provides guidance for acute spinal cord injury (SCI) management through an analytical assessment of the most recent evidence on therapies available for treating SCI, including...
6.
Weingarten M, Cokley J, Moffett B, DiCarlo S, Misra S
J Pediatr Pharmacol Ther . 2022 Jan; 27(1):29-37. PMID: 35002556
Objective: Early treatment of infantile spasms (IS) may be imperative for improvement of neurodevelopmental outcomes. Existing studies have led to inconclusive recommendations with variation in treatment. Our objective was to...